PL3082831T3 - Kompozycje oparte na metylocyklodekstrynach do leczenia i/lub zapobiegania chorobom poprzez podwyższenie poziomu cholesterolu HDL - Google Patents
Kompozycje oparte na metylocyklodekstrynach do leczenia i/lub zapobiegania chorobom poprzez podwyższenie poziomu cholesterolu HDLInfo
- Publication number
- PL3082831T3 PL3082831T3 PL14827505T PL14827505T PL3082831T3 PL 3082831 T3 PL3082831 T3 PL 3082831T3 PL 14827505 T PL14827505 T PL 14827505T PL 14827505 T PL14827505 T PL 14827505T PL 3082831 T3 PL3082831 T3 PL 3082831T3
- Authority
- PL
- Poland
- Prior art keywords
- cyclodextrines
- hdl
- enhancement
- treat
- compositions
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title 1
- 108010023302 HDL Cholesterol Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1362633A FR3014694B1 (fr) | 2013-12-13 | 2013-12-13 | Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl |
| PCT/FR2014/053309 WO2015087016A1 (fr) | 2013-12-13 | 2014-12-12 | Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl |
| EP14827505.0A EP3082831B1 (fr) | 2013-12-13 | 2014-12-12 | Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3082831T3 true PL3082831T3 (pl) | 2021-06-28 |
Family
ID=50424476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14827505T PL3082831T3 (pl) | 2013-12-13 | 2014-12-12 | Kompozycje oparte na metylocyklodekstrynach do leczenia i/lub zapobiegania chorobom poprzez podwyższenie poziomu cholesterolu HDL |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US10022392B2 (pl) |
| EP (2) | EP3581188A1 (pl) |
| JP (2) | JP6322289B2 (pl) |
| KR (3) | KR20160088874A (pl) |
| CN (2) | CN105792833B (pl) |
| AU (2) | AU2014363270B2 (pl) |
| BR (1) | BR112016013481A2 (pl) |
| CA (2) | CA2930489C (pl) |
| DK (1) | DK3082831T3 (pl) |
| ES (1) | ES2859609T3 (pl) |
| FR (1) | FR3014694B1 (pl) |
| MX (2) | MX388947B (pl) |
| PL (1) | PL3082831T3 (pl) |
| RU (1) | RU2677889C1 (pl) |
| WO (2) | WO2015087017A1 (pl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013296170A1 (en) | 2012-08-03 | 2015-03-12 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Cyclodextrin for the treatment of lysosomal storage diseases |
| WO2016201137A1 (en) * | 2015-06-10 | 2016-12-15 | Vtesse, Inc. | Hydroxypropyl beta-cyclodextrin compositions and methods |
| FR3042501B1 (fr) * | 2015-10-16 | 2017-11-03 | Roquette Freres | Nouvelles cyclodextrines methylees et leurs procedes de preparation |
| US20200000840A1 (en) * | 2016-03-20 | 2020-01-02 | Asdera Llc | Use of cyclodextrins to reduce endocytosis in malignant and neurodegenerative disorders |
| CA3030142A1 (en) * | 2016-07-08 | 2018-01-11 | Ranedis Pharmaceuticals, Llc | Compositions and methods of treating and/or preventing lysosomal storage diseases and other monogenetic metabolic diseases |
| KR101906578B1 (ko) * | 2017-07-28 | 2018-10-10 | 경북대학교 산학협력단 | 사이클로덱스트린 및 vegf 과발현 줄기세포를 유효성분으로 포함하는 퇴행성 신경질환의 예방 또는 치료용 약학적 조성물 |
| KR20200107927A (ko) | 2017-09-28 | 2020-09-16 | 아스데라 엘엘씨 | 인지질 조절장애를 수반하는 질환 및 장애에서의 시클로덱스트린의 용도 |
| CN107982546A (zh) * | 2017-12-05 | 2018-05-04 | 中国药科大学 | 基于主客体相互作用的酸敏感超分子纳米粒及其应用 |
| US12089930B2 (en) | 2018-03-05 | 2024-09-17 | Marquette University | Method and apparatus for non-invasive hemoglobin level prediction |
| CN108342473A (zh) * | 2018-04-13 | 2018-07-31 | 东华大学 | 一种用于检测血脂代谢相关基因abcg1甲基化的试剂盒 |
| FR3083234B1 (fr) * | 2018-06-29 | 2020-11-27 | Roquette Freres | Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation |
| SG11202013126QA (en) * | 2018-06-29 | 2021-02-25 | Roquette Freres | NOVEL HYDROXYPROPYL-ß-CYCLODEXTRIN AND PROCESS FOR THE PRODUCTION THEREOF |
| KR20210084480A (ko) * | 2018-10-29 | 2021-07-07 | 싸이클로 테라퓨틱스, 아이엔씨. | 알츠하이머 질환을 치료하는 방법 |
| CA3125554A1 (en) * | 2019-01-03 | 2020-07-09 | Underdog Pharmaceuticals, Inc. | Cyclodextrin dimers, compositions thereof, and uses thereof |
| US11446325B2 (en) * | 2020-09-30 | 2022-09-20 | Cyclolab Cyclodextrin Research And Development Laboratory Ltd. | Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases |
| FR3115682B1 (fr) * | 2020-11-05 | 2023-02-24 | Roquette Freres | Compositions à base de méthyl-cyclodextrines pour le traitement et/ou la prévention de la stéatose hépatique |
| AU2023220047A1 (en) | 2022-02-18 | 2024-09-19 | Beren Therapeutics P.B.C. | Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the same |
| WO2023156970A1 (en) * | 2022-02-18 | 2023-08-24 | Beren Therapeutics P.B.C. | Treatment of hypertriglyceridemia with 2-hydroxypropyl-beta-cyclodextrin |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62265230A (ja) * | 1986-05-12 | 1987-11-18 | Kao Corp | 高脂血症治療・予防剤 |
| BE1006873A6 (nl) * | 1993-03-26 | 1995-01-10 | Merkus Franciscus W H M | Toedieningsformulering voor nasale insuline toediening. |
| NZ505761A (en) | 1998-01-28 | 2003-08-29 | Warner Lambert Co | Method for treating alzheimer's disease using plasma-triglceride level-lowering agents or agents that interfer with cholesterol ester synthesis |
| JP2003514925A (ja) | 1999-11-12 | 2003-04-22 | ピサ・アンド・ピサ・エルエルシー | ベータ−シクロデキストリン及び関連化合物の部分メチルエーテルの結晶性混合物 |
| WO2001080715A2 (en) * | 2000-04-21 | 2001-11-01 | The Trustees Of Columbia University In The City Of New York | Methods for identifying compounds useful for preventing acute clinical vascular events in a subject |
| AUPR178300A0 (en) * | 2000-11-29 | 2000-12-21 | Heart Research Institute Ltd., The | Cyclodextrins and reversal of atherosclerosis |
| TW200307011A (en) * | 2002-04-18 | 2003-12-01 | Chugai Pharmaceutical Co Ltd | Hyaluronic acid modifier |
| EG24716A (en) * | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
| EP1781305A2 (en) * | 2004-08-13 | 2007-05-09 | Angiotech International Ag | Compositions and methods using hyaluronic acid and hyaluronidase inhibitors |
| GB0421176D0 (en) * | 2004-09-23 | 2004-10-27 | Poston Robin | Treatment of atherosclerosis |
| US9034846B2 (en) * | 2004-10-10 | 2015-05-19 | Universite De Liege | Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases |
| EP1655034A1 (en) | 2004-10-10 | 2006-05-10 | Université de Liège | Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases. |
| US7879821B2 (en) * | 2006-01-26 | 2011-02-01 | University Of Medicine And Dentistry Of New Jersey | Method for modulating inflammatory responses by altering plasma lipid levels |
| TW201006463A (en) * | 2008-06-26 | 2010-02-16 | Merz Pharma Gmbh & Co Kgaa | Pharmaceutical compositions comprising aminocyclohexane derivatives |
-
2013
- 2013-12-13 FR FR1362633A patent/FR3014694B1/fr active Active
-
2014
- 2014-12-12 PL PL14827505T patent/PL3082831T3/pl unknown
- 2014-12-12 JP JP2016538683A patent/JP6322289B2/ja active Active
- 2014-12-12 DK DK14827505.0T patent/DK3082831T3/da active
- 2014-12-12 KR KR1020167013320A patent/KR20160088874A/ko not_active Ceased
- 2014-12-12 CN CN201480065300.6A patent/CN105792833B/zh active Active
- 2014-12-12 EP EP19184268.1A patent/EP3581188A1/fr active Pending
- 2014-12-12 BR BR112016013481-8A patent/BR112016013481A2/pt not_active Application Discontinuation
- 2014-12-12 KR KR1020217042008A patent/KR102463677B1/ko active Active
- 2014-12-12 CA CA2930489A patent/CA2930489C/fr active Active
- 2014-12-12 MX MX2019003446A patent/MX388947B/es unknown
- 2014-12-12 WO PCT/FR2014/053310 patent/WO2015087017A1/fr not_active Ceased
- 2014-12-12 EP EP14827505.0A patent/EP3082831B1/fr active Active
- 2014-12-12 RU RU2016128411A patent/RU2677889C1/ru active
- 2014-12-12 CA CA3180528A patent/CA3180528A1/fr active Pending
- 2014-12-12 KR KR1020217017348A patent/KR102453643B1/ko active Active
- 2014-12-12 ES ES14827505T patent/ES2859609T3/es active Active
- 2014-12-12 AU AU2014363270A patent/AU2014363270B2/en active Active
- 2014-12-12 US US15/039,864 patent/US10022392B2/en active Active
- 2014-12-12 WO PCT/FR2014/053309 patent/WO2015087016A1/fr not_active Ceased
- 2014-12-12 MX MX2016007658A patent/MX381039B/es unknown
- 2014-12-12 CN CN201910316561.5A patent/CN110123831A/zh active Pending
-
2018
- 2018-02-23 US US15/903,738 patent/US11266680B2/en active Active
- 2018-04-06 JP JP2018073664A patent/JP2018123153A/ja active Pending
-
2020
- 2020-01-23 AU AU2020200500A patent/AU2020200500B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3082831T3 (pl) | Kompozycje oparte na metylocyklodekstrynach do leczenia i/lub zapobiegania chorobom poprzez podwyższenie poziomu cholesterolu HDL | |
| IL273090B (en) | Methods and preparations for the treatment of cancer | |
| EP3024457A4 (en) | Compositions to improve the therapeutic benefit of bisantrene | |
| IL245408B (en) | Converted benzamides for the treatment of arthropods | |
| IL244677B (en) | Effective preparations for the treatment of kit-related disorders | |
| IL246252A0 (en) | Diaminopyrimidyl derivative compounds, their compositions and methods of treatment | |
| SG11201601412XA (en) | Compositions and methods for the treatment of presbyopia | |
| HUE051373T2 (hu) | Készítmények MPSI kezelésére | |
| EP3169784A4 (en) | Organic compositions to treat apoc3-related diseases | |
| SG11201506805QA (en) | Organic compositions to treat epas1-related diseases | |
| GB201404403D0 (en) | Compositions and methods relating to the treatment of diseases | |
| SG10201705899XA (en) | Prevention & treatment of neuropathy | |
| PL2968478T3 (pl) | Kompozycje i sposoby do leczenia karboksyhemoglobinemii | |
| EP3010504A4 (en) | Methods and compositions to treat cancer | |
| ZA201506392B (en) | Compositions and methods including celecoxib and plumbagin relating to treatment of cancer | |
| ZA201509360B (en) | Compositions and methods for treatment of stroke | |
| PL3079684T3 (pl) | Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna | |
| SG11201509640RA (en) | Use of an isopropanol-containing solution to combat calciviridae | |
| PT3041488T (pt) | Composições de mel | |
| ZA201404930B (en) | Plant treatment composition | |
| AU2013903871A0 (en) | Compositions for treating skin conditions |